![Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology](https://bwcbuildout.com/jcad/wp-content/uploads/ShahFeb2020Figure3.jpg)
Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology
![Acute Onset Linear Lichen Planus Pigmentosus of the Forehead: A Case Series - Next Steps in Dermatology Acute Onset Linear Lichen Planus Pigmentosus of the Forehead: A Case Series - Next Steps in Dermatology](https://nextstepsinderm.com/wp-content/uploads/2023/04/LPP_Case-Report-2.png)
Acute Onset Linear Lichen Planus Pigmentosus of the Forehead: A Case Series - Next Steps in Dermatology
![Bilateral Symmetrical Oval Hyperpigmentation on the Face: A Case of Seborrheic Melanosis | Journal of Skin and Stem Cell | Full Text Bilateral Symmetrical Oval Hyperpigmentation on the Face: A Case of Seborrheic Melanosis | Journal of Skin and Stem Cell | Full Text](https://services.brieflands.com/cdn/serve/31641/fcb78daabcc644b5dffb5027ad823bf0e38897ca/jssc-10-1-135821-g002-preview.png)
Bilateral Symmetrical Oval Hyperpigmentation on the Face: A Case of Seborrheic Melanosis | Journal of Skin and Stem Cell | Full Text
![Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines - ScienceDirect Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0190962204005171-gr4.jpg)
Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines - ScienceDirect
![Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part I, efficacy - ScienceDirect Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part I, efficacy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0190962201800049-gr8.jpg)
Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part I, efficacy - ScienceDirect
![Figure 3 from A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. | Semantic Scholar Figure 3 from A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/28bc79d3c17d5baf8a581c3d814375f1bac17e2d/3-Figure3-1.png)
Figure 3 from A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. | Semantic Scholar
![Utility of dermoscopy for evaluating the therapeutic efficacy of tacrolimus ointment plus 308-nm excimer laser combination therapy in localized vitiligo patients Utility of dermoscopy for evaluating the therapeutic efficacy of tacrolimus ointment plus 308-nm excimer laser combination therapy in localized vitiligo patients](https://www.spandidos-publications.com/article_images/etm/15/4/etm-15-04-3981-g00.jpg)
Utility of dermoscopy for evaluating the therapeutic efficacy of tacrolimus ointment plus 308-nm excimer laser combination therapy in localized vitiligo patients
![Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology](https://bwcbuildout.com/jcad/wp-content/uploads/ShahFeb2020Figure10.jpg)
Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology
![Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology](https://gnq.fic.mybluehost.me/jcad-online-backup/wp-content/uploads/ShahFeb2020Figure6.jpg)
Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology
![PA lesion treated with 0.1% tacrolimus ointment in a 7-year-old boy:... | Download Scientific Diagram PA lesion treated with 0.1% tacrolimus ointment in a 7-year-old boy:... | Download Scientific Diagram](https://www.researchgate.net/publication/224940533/figure/fig1/AS:302874681724929@1449222359380/PA-lesion-treated-with-01-tacrolimus-ointment-in-a-7-year-old-boy-onset-and-8-weeks.png)
PA lesion treated with 0.1% tacrolimus ointment in a 7-year-old boy:... | Download Scientific Diagram
![Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology](https://bwcbuildout.com/jcad/wp-content/uploads/ShahFeb2020Figure2.jpg)
Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology
![Seborrheic melanosis: An entity worthy of mention in dermatological literature - Indian Journal of Dermatology, Venereology and Leprology Seborrheic melanosis: An entity worthy of mention in dermatological literature - Indian Journal of Dermatology, Venereology and Leprology](https://ijdvl.com/content/126/2017/83/3/images/ijdvl_2017_83_3_285_203248_f4.jpg)
Seborrheic melanosis: An entity worthy of mention in dermatological literature - Indian Journal of Dermatology, Venereology and Leprology
![Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology](https://bwcbuildout.com/jcad/wp-content/uploads/ShahFeb2020Figure5.jpg)
Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology
![Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology](https://gnq.fic.mybluehost.me/jcad-online-backup/wp-content/uploads/ShahFeb2020Figure8.jpg)
Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology
![A combination of excimer laser treatment and topical tacrolimus is more effective in treating vitiligo than either therapy alone for the initial 6 months, but not thereafter - Park - 2016 - A combination of excimer laser treatment and topical tacrolimus is more effective in treating vitiligo than either therapy alone for the initial 6 months, but not thereafter - Park - 2016 -](https://onlinelibrary.wiley.com/cms/asset/eddc8aed-f8e1-42e1-a283-c825d23374ad/ced12742-fig-0001-m.png)
A combination of excimer laser treatment and topical tacrolimus is more effective in treating vitiligo than either therapy alone for the initial 6 months, but not thereafter - Park - 2016 -
![Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology](https://gnq.fic.mybluehost.me/jcad-online-backup/wp-content/uploads/ShahFeb2020Figure12.jpg)
Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology
![Tacrolimus ointment promotes repigmentation of vitiligo in children: A review of 57 cases - ScienceDirect Tacrolimus ointment promotes repigmentation of vitiligo in children: A review of 57 cases - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0190962204015774-gr2.jpg)
Tacrolimus ointment promotes repigmentation of vitiligo in children: A review of 57 cases - ScienceDirect
![Bilateral Symmetrical Oval Hyperpigmentation on the Face: A Case of Seborrheic Melanosis | Journal of Skin and Stem Cell | Full Text Bilateral Symmetrical Oval Hyperpigmentation on the Face: A Case of Seborrheic Melanosis | Journal of Skin and Stem Cell | Full Text](https://services.brieflands.com/cdn/serve/31641/7b0cef27d029a9d2f4507fd0212e86f1af313851/jssc-10-1-135821-g001-preview.png)